Showing results (171-180 of 274) with videos related to

Sort By:
Pageof 28
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 14, 2023
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosisRoeland Vis, Harold Mathijssen, Ruth G M Keijsers, et al.
Respiratory Medicine|March 3, 2018
Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosisMilou C Schimmelpennink, Adriane D M Vorselaars, Frouke T van Beek, et al.
The European Respiratory Journal|November 13, 2025
Sarcoidosis: A State-Of-The-Art ReviewJelle R Miedema, Francesco Bonella, Katharina Buschulte, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|February 6, 2016
Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trialRobert P Baughman, Marc A Judson, Elyse E Lower, et al.
International Journal of Molecular Sciences|August 26, 2023
Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with SarcoidosisRaisa Kraaijvanger, Carmen A Ambarus, Jan Damen, et al.
Chest|October 12, 2017
Higher Priced Older Pharmaceuticals: How Should We Respond?Richard S Irwin, Scott Manaker, Mark L Metersky, et al.
The Lancet. Respiratory Medicine|November 25, 2022
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trialVivienne Kahlmann, Catharina C Moor, Sanne J van Helmondt, et al.
BMC Pulmonary Medicine|October 20, 2020
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH studyVivienne Kahlmann, Montse Janssen Bonás, Catharina C Moor, et al.
Respiratory Medicine|November 21, 2024
Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosisAda E M Bloem, Hanneke M Dolk, Anne E Wind, et al.
Lung|June 21, 2023
Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated PatientsMark G J P Platenburg, Coline H M van Moorsel, Ivo A Wiertz, et al.
Pageof 28